Drug Type siRNA |
Synonyms SCAP siRNA, LY 3885125, LY3885125 |
Target |
Action modulators |
Mechanism SCAP modulators(SREBF chaperone modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dyslipidemias | Phase 1 | United States | 10 Aug 2023 | |
Metabolic dysfunction-associated steatotic liver disease | Phase 1 | United States | 10 Aug 2023 |